News
2011
curasan AG receives European license for bone regeneration material with optimised handling features
Kleinostheim, 22.08.2011 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has received the European approval for Cerasorb® foam for two different product versions...
curasan AG signs exclusive sales agreement with Zimmer Dental Inc., USA
Kleinostheim, Germany, July 25, 2011 – curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), has signed an agreement which provides Zimmer Dental Inc, Carlsbad, CA, (USA) with exclusive global distribution rights for Osbone®, Ceracell® and Osseolive® synthetic bone grafting products for regenerative dental applications....
curasan Inc. and TransCorp Spine Inc. sign supply agreement for the US-market
Kleinostheim, Germany, 11th January 2011 – curasan Inc., the north American subsidiary of exchange listed curasan AG, Germany, (ISIN: DE 000 549 453 8), has signed an exclusive supply agreement with TransCorp Spine Inc., Michigan, USA, for Cerasorb® Ortho block forms ...